Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
Oncaspar liquid (pegaspargase)
i
Other names:
PEG-L-asp, SHP674, S95014 liquid, SHP-674, SHP 674
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(6)
News
Trials
Company:
Servier
Drug class:
Asparagine depleter, Aspartate-ammonia ligase inhibitor
Related drugs:
‹
calaspargase pegol-mknl (2)
recombinant (2)
eryaspase (1)
L-asparaginase (0)
pegaspargase lyophilized (0)
PEGylated recombinant Erwinia chrysantemi-derived L-asparaginase (0)
erwinia asparaginase (0)
L-asparaginase (0)
asparaginase Escherichia coli (0)
JZP341 (0)
calaspargase pegol-mknl (2)
recombinant (2)
eryaspase (1)
L-asparaginase (0)
pegaspargase lyophilized (0)
PEGylated recombinant Erwinia chrysantemi-derived L-asparaginase (0)
erwinia asparaginase (0)
L-asparaginase (0)
asparaginase Escherichia coli (0)
JZP341 (0)
›
Associations
(6)
News
Trials
Phase
Status
Apply
Phase
Status
Apply
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk B Acute Lymphoblastic Leukemia and Ph-Like TKI Sensitive Mutations (AALL1131) (NCT02883049)
Phase 3
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Active, not recruiting
Phase 3
National Cancer Institute (NCI)
Active, not recruiting
Last update posted :
02/21/2025
Initiation :
02/29/2012
Primary completion :
12/31/2022
Completion :
10/03/2025
ABL1 • BCR • RUNX1 • KMT2A • ETV6
|
MLL rearrangement
|
dasatinib • cytarabine • doxorubicin hydrochloride • cyclophosphamide • etoposide IV • methotrexate • vincristine • prednisone • daunorubicin • clofarabine • leucovorin calcium • Oncaspar liquid (pegaspargase) • mercaptopurine delayed release (DR6MP) • mercaptopurine • thioguanine • Hemady (dexamethasone tablets) • Starasid (cytarabine ocfosfate) • cyclophosphamide intravenous
A Study Comparing the Combination of Dasatinib and Chemotherapy Treatment With or Without Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or Philadelphia Chromosome-Like (Ph-Like) ABL-Class B-Cell Acute Lymphoblastic Leukemia (B-ALL) (NCT06124157)
Phase 3
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Not yet recruiting
Phase 3
National Cancer Institute (NCI)
Not yet recruiting
Last update posted :
02/14/2025
Initiation :
05/29/2025
Primary completion :
12/01/2030
Completion :
12/01/2030
ABL1 • KIT • PDGFRA • CD19 • PDGFRB • CSF1R
|
CD19 expression
|
dasatinib • imatinib • cytarabine • doxorubicin hydrochloride • cyclophosphamide • Blincyto (blinatumomab) • methotrexate • vincristine • daunorubicin • leucovorin calcium • Oncaspar liquid (pegaspargase) • mercaptopurine • Asparlas (calaspargase pegol-mknl) • thioguanine • Starasid (cytarabine ocfosfate)
Inotuzumab Ozogamicin in Treating Younger Patients With B-Lymphoblastic Lymphoma or Relapsed or Refractory CD22 Positive B Acute Lymphoblastic Leukemia (AALL1621) (NCT02981628)
Phase 2
Children's Oncology Group
Children's Oncology Group
Recruiting
Phase 2
Children's Oncology Group
Recruiting
Last update posted :
02/13/2025
Initiation :
06/19/2017
Primary completion :
03/31/2026
Completion :
03/31/2026
KMT2A • CD22
|
MLL rearrangement • CD22 expression
|
cytarabine • cyclophosphamide • methotrexate • Besponsa (inotuzumab ozogamicin) • vincristine • leucovorin calcium • Oncaspar liquid (pegaspargase) • mercaptopurine delayed release (DR6MP) • mercaptopurine • Asparlas (calaspargase pegol-mknl) • Rylaze (asparaginase erwinia chrysanthemi (recombinant)-rywn) • Starasid (cytarabine ocfosfate) • cyclophosphamide intravenous
Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (AALL1631) (NCT03007147)
Phase 3
Children's Oncology Group
Children's Oncology Group
Active, not recruiting
Phase 3
Children's Oncology Group
Active, not recruiting
Last update posted :
02/13/2025
Initiation :
08/08/2017
Primary completion :
09/30/2027
Completion :
09/30/2027
ABL1 • BCR • PDGFRA • PDGFRB • IKZF1 • CSF1R
|
BCR-ABL1 fusion • ABL1 fusion
|
imatinib • cytarabine • doxorubicin hydrochloride • cyclophosphamide • ifosfamide • etoposide IV • methotrexate • vincristine • daunorubicin • dexamethasone • leucovorin calcium • Oncaspar liquid (pegaspargase) • mercaptopurine delayed release (DR6MP) • mercaptopurine • Asparlas (calaspargase pegol-mknl) • thioguanine • Hemady (dexamethasone tablets) • Neupogen (filgrastim) • Starasid (cytarabine ocfosfate) • cyclophosphamide intravenous • dexrazoxane • levoleucovorin calcium • prednisolone
A Study of Revumenib in Combination With Chemotherapy for Patients Diagnosed With Relapsed or Refractory Leukemia (NCT05761171)
Phase 2
Children's Oncology Group
Children's Oncology Group
Recruiting
Phase 2
Children's Oncology Group
Recruiting
Last update posted :
02/13/2025
Initiation :
01/08/2024
Primary completion :
12/31/2027
Completion :
12/31/2027
KMT2A
|
MLL rearrangement
|
cytarabine • methotrexate • vincristine • Revuforj (revumenib) • Oncaspar liquid (pegaspargase) • fludarabine IV • Asparlas (calaspargase pegol-mknl) • Starasid (cytarabine ocfosfate)
Studying the Effect of Levocarnitine in Protecting the Liver From Chemotherapy for Leukemia or Lymphoma (NCT05602194)
Phase 3
Children's Oncology Group
Children's Oncology Group
Recruiting
Phase 3
Children's Oncology Group
Recruiting
Last update posted :
02/12/2025
Initiation :
08/24/2023
Primary completion :
06/30/2028
Completion :
12/30/2028
CRLF2 • PNPLA3 • SOD2
|
Oncaspar liquid (pegaspargase) • Asparlas (calaspargase pegol-mknl)
Low-Intensity Chemotherapy and Venetoclax in Treating Patients With Relapsed or Refractory B- or T-Cell Acute Lymphoblastic Leukemia (NCT03808610)
Phase 1/2
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Active, not recruiting
Phase 1/2
M.D. Anderson Cancer Center
Active, not recruiting
Last update posted :
02/10/2025
Initiation :
04/03/2019
Primary completion :
12/31/2026
Completion :
12/31/2026
BCL2
|
BCL2 expression
|
Venclexta (venetoclax) • Rituxan (rituximab) • cytarabine • cyclophosphamide • methotrexate • vincristine • Oncaspar liquid (pegaspargase) • Truxima (rituximab-abbs) • nelarabine • Riabni (rituximab-arrx) • Delito (rituximab biosimilar) • GB241 (rituximab biosimilar) • Novex (rituximab biosimilar) • Starasid (cytarabine ocfosfate) • cyclophosphamide intravenous
Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia (ECOG-ACRIN E1910) (NCT02003222)
Phase 3
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Active, not recruiting
Phase 3
National Cancer Institute (NCI)
Active, not recruiting
Last update posted :
02/06/2025
Initiation :
05/19/2014
Primary completion :
06/23/2023
Completion :
03/14/2025
ABL1 • BCR • CDKN2A • RUNX1 • IGH • ETV6 • CD4 • TCF3 • PBX1
|
Rituxan (rituximab) • cytarabine • cyclophosphamide • etoposide IV • Blincyto (blinatumomab) • methotrexate • vincristine • prednisone • daunorubicin • dexamethasone • leucovorin calcium • Oncaspar liquid (pegaspargase) • Truxima (rituximab-abbs) • mercaptopurine delayed release (DR6MP) • mercaptopurine • Riabni (rituximab-arrx) • Delito (rituximab biosimilar) • Hemady (dexamethasone tablets) • GB241 (rituximab biosimilar) • JHL1101 (rituximab biosimilar) • Mabtas (rituximab biosimilar) • Novex (rituximab biosimilar) • SIBP-02 (rituximab biosimilar) • Starasid (cytarabine ocfosfate) • cyclophosphamide intravenous
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma (AALL0434) (NCT00408005)
Phase 3
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Active, not recruiting
Phase 3
National Cancer Institute (NCI)
Active, not recruiting
Last update posted :
02/04/2025
Initiation :
01/22/2007
Primary completion :
09/30/2017
Completion :
03/07/2025
CD20 • CD8 • CD22 • CD34 • CD5 • CD7 • CD2 • MPO
|
CD22 expression
|
cytarabine • doxorubicin hydrochloride • cyclophosphamide • methotrexate • vincristine • daunorubicin • dexamethasone • leucovorin calcium • Oncaspar liquid (pegaspargase) • mercaptopurine delayed release (DR6MP) • nelarabine • mercaptopurine • thioguanine • Hemady (dexamethasone tablets) • Kidrolase (L-asparaginase) • Leunase (L-asparaginase) • Spectrila (asparaginase Escherichia coli) • Starasid (cytarabine ocfosfate) • cyclophosphamide intravenous • dexamethasone injection
Combination Chemotherapy With or Without Bortezomib in Treating Younger Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Stage II-IV T-Cell Lymphoblastic Lymphoma (AALL1231) (NCT02112916)
Phase 3
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Active, not recruiting
Phase 3
National Cancer Institute (NCI)
Active, not recruiting
Last update posted :
02/04/2025
Initiation :
10/04/2014
Primary completion :
03/31/2020
Completion :
09/18/2025
CD20 • CD8 • CD22 • CD34 • CD5 • CD7 • CD2 • MPO
|
CD22 expression
|
cytarabine • bortezomib • doxorubicin hydrochloride • cyclophosphamide • ifosfamide • etoposide IV • methotrexate • vincristine • daunorubicin • leucovorin calcium • Oncaspar liquid (pegaspargase) • mercaptopurine delayed release (DR6MP) • mercaptopurine • thioguanine • Hemady (dexamethasone tablets) • Starasid (cytarabine ocfosfate) • cyclophosphamide intravenous
A Study of JNJ-75276617 in Combination With Conventional Chemotherapy for Pediatric and Young Adult Participants With Relapsed/Refractory Acute Leukemias (NCT05521087)
Phase 1
Janssen Research & Development, LLC
Janssen Research & Development, LLC
Withdrawn
Phase 1
Janssen Research & Development, LLC
Withdrawn
Last update posted :
02/03/2025
Initiation :
12/26/2025
Primary completion :
09/11/2026
Completion :
01/29/2030
NPM1 • KMT2A • NUP98 • NUP214
|
cytarabine • vincristine • Oncaspar liquid (pegaspargase) • fludarabine IV • bleximenib (JNJ-6617)
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia (NCT06317662)
Phase 2
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Not yet recruiting
Phase 2
National Cancer Institute (NCI)
Not yet recruiting
Last update posted :
01/29/2025
Initiation :
04/26/2025
Primary completion :
12/31/2028
Completion :
12/31/2028
MCL1 • KMT2A • BCL2L1
|
BCL2 expression
|
Venclexta (venetoclax) • cytarabine • doxorubicin hydrochloride • cyclophosphamide • Blincyto (blinatumomab) • methotrexate • vincristine • daunorubicin • leucovorin calcium • Oncaspar liquid (pegaspargase) • mercaptopurine • Asparlas (calaspargase pegol-mknl) • Rylaze (asparaginase erwinia chrysanthemi (recombinant)-rywn) • thioguanine • Hemady (dexamethasone tablets) • Starasid (cytarabine ocfosfate) • prednisolone
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia (NCT03150693)
Phase 3
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology
Suspended
Phase 3
Alliance for Clinical Trials in Oncology
Suspended
Last update posted :
05/23/2024
Initiation :
06/01/2017
Primary completion :
03/01/2025
Completion :
08/01/2025
ABL1 • BCR • CD20 • CD22 • ITGB1
|
CD20 positive • CD22 positive
|
Rituxan (rituximab) • cytarabine • doxorubicin hydrochloride • cyclophosphamide • Besponsa (inotuzumab ozogamicin) • vincristine • daunorubicin • Oncaspar liquid (pegaspargase) • mercaptopurine • thioguanine • cyclophosphamide intravenous
Standard Chemotherapy With or Without Nelarabine or Rituximab in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia (UKALL14) (NCT01085617)
Phase 3
University College, London
University College, London
Active, not recruiting
Phase 3
University College, London
Active, not recruiting
Last update posted :
05/10/2024
Initiation :
12/01/2010
Primary completion :
12/01/2024
Completion :
12/01/2025
ABL1 • BCR • MYC
|
MYC translocation • Chr t(4;11)(q21;q23)
|
Rituxan (rituximab) • imatinib • cytarabine • cyclophosphamide • etoposide IV • vincristine • daunorubicin • melphalan • Oncaspar liquid (pegaspargase) • fludarabine IV • nelarabine • mercaptopurine • Kepivance (palifermin)
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL) (AALL1821) (NCT04546399)
Phase 2
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Suspended
Phase 2
National Cancer Institute (NCI)
Suspended
Last update posted :
04/18/2024
Initiation :
12/04/2020
Primary completion :
06/30/2028
Completion :
06/30/2028
CD19
|
CD19 expression
|
Opdivo (nivolumab) • cytarabine • doxorubicin hydrochloride • cyclophosphamide • etoposide IV • Blincyto (blinatumomab) • methotrexate • vincristine • dexamethasone • leucovorin calcium • Oncaspar liquid (pegaspargase) • mercaptopurine delayed release (DR6MP) • mercaptopurine • thioguanine • Hemady (dexamethasone tablets) • Starasid (cytarabine ocfosfate) • cyclophosphamide intravenous • dexamethasone injection
Low-Dose or High-Dose Vincristine and Combination Chemotherapy in Treating Young Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia (AALL0433) (NCT00381680)
Phase 3
Children's Oncology Group
Children's Oncology Group
Completed
Phase 3
Children's Oncology Group
Completed
Last update posted :
03/26/2024
Initiation :
03/01/2007
Primary completion :
03/01/2016
MYC
|
MYC translocation
|
cytarabine • doxorubicin hydrochloride • cyclophosphamide • etoposide IV • vincristine • prednisone • leucovorin calcium • Oncaspar liquid (pegaspargase) • mercaptopurine delayed release (DR6MP) • mercaptopurine • Kidrolase (L-asparaginase) • Neupogen (filgrastim) • cyclophosphamide intravenous
Azacitidine and Combination Chemotherapy in Treating Infants With Acute Lymphoblastic Leukemia and KMT2A Gene Rearrangement (AALL15P1) (NCT02828358)
Phase 2
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Active, not recruiting
Phase 2
National Cancer Institute (NCI)
Active, not recruiting
Last update posted :
03/25/2024
Initiation :
04/01/2017
Primary completion :
09/30/2020
Completion :
09/22/2024
KMT2A
|
KMT2A rearrangement • MLL rearrangement
|
cytarabine • azacitidine • cyclophosphamide • methotrexate • vincristine • daunorubicin • leucovorin calcium • Oncaspar liquid (pegaspargase) • mercaptopurine • thioguanine • Hemady (dexamethasone tablets) • Starasid (cytarabine ocfosfate) • cyclophosphamide intravenous
Total Therapy XVII for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia and Lymphoma (NCT03117751)
Phase 2/3
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
Active, not recruiting
Phase 2/3
St. Jude Children's Research Hospital
Active, not recruiting
Last update posted :
03/05/2024
Initiation :
03/29/2017
Primary completion :
09/30/2026
Completion :
03/31/2028
BCL2 • CEP72
|
dasatinib • cytarabine • bortezomib • doxorubicin hydrochloride • Jakafi (ruxolitinib) • cyclophosphamide • etoposide IV • Blincyto (blinatumomab) • methotrexate • vincristine • prednisone • daunorubicin • Zolinza (vorinostat) • clofarabine • idarubicin hydrochloride • Oncaspar liquid (pegaspargase) • mercaptopurine delayed release (DR6MP) • nelarabine • Asparlas (calaspargase pegol-mknl) • Rylaze (asparaginase erwinia chrysanthemi (recombinant)-rywn) • thioguanine • Erwinase (erwinia asparaginase) • Purixan (mercaptopurine oral suspension) • cyclophosphamide intravenous • prednisolone
Tislelizumab Combined Treatment in Refractory Extranodal NK/T-cell Lymphoma (NCT05058755)
Phase N/A
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Xinhua Hospital, Shanghai Jiao Tong Uni...
Completed
Phase N/A
Xinhua Hospital, Shanghai Jiao Tong University ...
Completed
Last update posted :
03/04/2024
Initiation :
09/17/2021
Primary completion :
12/30/2022
Completion :
12/30/2023
PD-L1
|
lenalidomide • Tevimbra (tislelizumab-jsgr) • azacitidine • etoposide IV • Oncaspar liquid (pegaspargase)
A Phase 2 Study of Ruxolitinib With Chemotherapy in Children With Acute Lymphoblastic Leukemia (AALL1521) (NCT02723994)
Phase 2
Incyte Corporation
Incyte Corporation
Active, not recruiting
Phase 2
Incyte Corporation
Active, not recruiting
Last update posted :
01/12/2024
Initiation :
09/30/2016
Primary completion :
02/01/2026
Completion :
02/01/2026
JAK2 • CRLF2 • JAK1 • IL7R • EPOR • SH2B3
|
CRLF2 rearrangement • JAK2 mutation • IL7R mutation • JAK2 fusion • SH2B3 deletion
|
cytarabine • doxorubicin hydrochloride • Jakafi (ruxolitinib) • cyclophosphamide • vincristine • prednisone • leucovorin calcium • Oncaspar liquid (pegaspargase) • mercaptopurine • thioguanine • Erwinase (erwinia asparaginase)
Ruxolitinib and Chemotherapy in Adolescents and Young Adults With Ph-like Acute Lymphoblastic Leukemia (NCT03571321)
Phase 1
University of Chicago
University of Chicago
Recruiting
Phase 1
University of Chicago
Recruiting
Last update posted :
11/29/2023
Initiation :
05/28/2019
Primary completion :
09/01/2026
Completion :
09/05/2027
JAK2 • CRLF2 • IL7R • SH2B3
|
CRLF2 rearrangement • JAK2 mutation • IL7R mutation • JAK2 rearrangement • SH2B3 deletion
|
Rituxan (rituximab) • cytarabine • doxorubicin hydrochloride • Jakafi (ruxolitinib) • cyclophosphamide • vincristine • Oncaspar liquid (pegaspargase) • mercaptopurine • thioguanine • cyclophosphamide intravenous
Phase I Study of Inotuzumab With Augmented BFM Re-Induction for Patients With Relapsed/Refractory B-cell ALL (ALL 001) (NCT03962465)
Phase 1
University of Virginia
University of Virginia
Active, not recruiting
Phase 1
University of Virginia
Active, not recruiting
Last update posted :
08/22/2023
Initiation :
07/22/2022
Primary completion :
07/15/2023
Completion :
07/01/2026
CD22
|
CD22 positive
|
cytarabine • methotrexate • Besponsa (inotuzumab ozogamicin) • vincristine • prednisone • daunorubicin • Oncaspar liquid (pegaspargase)
Combination Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia (NCT00005585)
Phase 3
Children's Oncology Group
Children's Oncology Group
Completed
Phase 3
Children's Oncology Group
Completed
Last update posted :
04/06/2023
Initiation :
04/01/2000
Primary completion :
07/01/2007
KMT2A
|
MLL rearrangement • MLL rearrangement
|
cytarabine • cyclophosphamide • vincristine • daunorubicin • leucovorin calcium • Oncaspar liquid (pegaspargase) • mercaptopurine • thioguanine • Kidrolase (L-asparaginase)
Pediatric-inspired Regimen Combined With Venetoclax for Adolescent and Adult Patients With de Novo Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia (NCT05660473)
Phase 2
Institute of Hematology & Blood Diseases Hospital
Institute of Hematology & Blood Disease...
Recruiting
Phase 2
Institute of Hematology & Blood Diseases Hospital
Recruiting
Last update posted :
03/03/2023
Initiation :
10/31/2022
Primary completion :
12/15/2024
Completion :
12/30/2027
ABL1 • BCR
|
Venclexta (venetoclax) • cytarabine • cyclophosphamide • vincristine • prednisone • daunorubicin • dexamethasone • Oncaspar liquid (pegaspargase) • mercaptopurine
Therapy for Pediatric Relapsed or Refractory Precursor B-Cell Acute Lymphoblastic Leukemia and Lymphoma (NCT01700946)
Phase 2
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
Completed
Phase 2
St. Jude Children's Research Hospital
Completed
Last update posted :
09/28/2022
Initiation :
04/15/2013
Primary completion :
07/24/2021
Completion :
07/24/2021
CD20
|
CD20 expression
|
Rituxan (rituximab) • cytarabine • cyclophosphamide • etoposide IV • methotrexate • vincristine • clofarabine • mitoxantrone • Oncaspar liquid (pegaspargase) • Vumon (teniposide) • mercaptopurine • vinblastine • Proleukin (aldesleukin) • cyclophosphamide intravenous
Palbociclib in Combination With Chemotherapy in Treating Children With Relapsed Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LL) (NCT03792256)
Phase 1
Children's Oncology Group
Children's Oncology Group
Active, not recruiting
Phase 1
Children's Oncology Group
Active, not recruiting
Last update posted :
03/02/2022
Initiation :
04/11/2019
Primary completion :
06/30/2021
Completion :
06/30/2025
RB1 • CD8 • CDK4 • CDK6 • CD4 • CCND3
|
RB1 expression • CDK6 expression • CDKN1B expression
|
Ibrance (palbociclib) • cytarabine • doxorubicin hydrochloride • vincristine • prednisone • Oncaspar liquid (pegaspargase) • prednisolone
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia (CALGB 10403) (NCT00558519)
Phase 2
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology
Active, not recruiting
Phase 2
Alliance for Clinical Trials in Oncology
Active, not recruiting
Last update posted :
08/18/2021
Initiation :
03/12/2008
Primary completion :
09/01/2016
ABL1 • BCR
|
cytarabine • doxorubicin hydrochloride • cyclophosphamide • vincristine • daunorubicin • Oncaspar liquid (pegaspargase) • mercaptopurine • thioguanine
A Prospective Clinical Study of Ruxolitinib and Etoposide Combined With DDGP Regimen (RUE-DDGP) in Induction Therapy of T/NK Cell Lymphoma-associated Hemophagocytic Syndrome. (NCT04999878)
Phase 4
Zhengzhou University
Zhengzhou University
Recruiting
Phase 4
Zhengzhou University
Recruiting
Last update posted :
08/11/2021
Initiation :
05/30/2021
Primary completion :
06/30/2023
Completion :
06/30/2024
IL2 • CD27 • XIAP • PRF1 • UNC13D • ISG20 • RAB27A • STXBP2
|
gemcitabine • Jakafi (ruxolitinib) • etoposide IV • dexamethasone • Oncaspar liquid (pegaspargase)
Dasatinib and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia (AALL0622) (NCT00720109)
Phase 2/3
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Completed
Phase 2/3
National Cancer Institute (NCI)
Completed
Last update posted :
04/13/2020
Initiation :
07/14/2008
Primary completion :
12/31/2014
Completion :
03/31/2020
ABL1 • BCR
|
dasatinib • cytarabine • cyclophosphamide • ifosfamide • etoposide IV • methotrexate • vincristine • daunorubicin • leucovorin calcium • Oncaspar liquid (pegaspargase) • mercaptopurine • Kidrolase (L-asparaginase) • Leunase (L-asparaginase) • Neupogen (filgrastim) • Spectrila (asparaginase Escherichia coli) • Starasid (cytarabine ocfosfate)
Different Therapies in Treating Infants With Newly Diagnosed Acute Leukemia (Interfant06) (NCT00550992)
Phase N/A
Dutch Childhood Oncology Group
Dutch Childhood Oncology Group
Unknown status
Phase N/A
Dutch Childhood Oncology Group
Unknown status
Last update posted :
07/30/2019
Initiation :
01/01/2006
Primary completion :
12/01/2020
KMT2A • CD34
|
MLL rearrangement • MLL rearrangement • CD34 positive
|
cytarabine • cyclophosphamide • etoposide IV • vincristine • prednisone • daunorubicin • mitoxantrone • leucovorin calcium • melphalan • Oncaspar liquid (pegaspargase) • mercaptopurine • busulfan • thioguanine • cyclosporine • prednisolone
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia (AALL1131) (NCT01406756)
Phase 3
Children's Oncology Group
Children's Oncology Group
Recruiting
Phase 3
Children's Oncology Group
Recruiting
Last update posted :
12/13/2017
Initiation :
02/01/2012
Primary completion :
08/01/2021
ABL1 • BCR • RUNX1 • KMT2A • ETV6
|
MLL rearrangement • MLL rearrangement
|
cytarabine • doxorubicin hydrochloride • cyclophosphamide • etoposide IV • methotrexate • vincristine • prednisone • dexamethasone • clofarabine • leucovorin calcium • Oncaspar liquid (pegaspargase) • mercaptopurine delayed release (DR6MP) • mercaptopurine • thioguanine • Starasid (cytarabine ocfosfate) • cyclophosphamide intravenous • dexamethasone injection • methylprednisolone sodium succinate
Chemoimmunotherapy With Epratuzumab in Relapsed Acute Lymphoblastic Leukemia (ALL) (NCT00098839)
Phase 2
Children's Oncology Group
Children's Oncology Group
Completed
Phase 2
Children's Oncology Group
Completed
Last update posted :
12/12/2017
Initiation :
02/01/2005
Primary completion :
04/01/2011
Completion :
04/01/2011
CD22
|
CD22 expression
|
cytarabine • doxorubicin hydrochloride • cyclophosphamide • etoposide IV • prednisone • leucovorin calcium • Oncaspar liquid (pegaspargase) • Marqibo (vincristine liposomal) • Epratucyn (epratuzumab) • Neupogen (filgrastim) • cyclophosphamide intravenous • dexrazoxane
Combination Chemotherapy and Radiation Therapy in Treating Patients With Acute Lymphoblastic Leukemia That Has Relapsed in the CNS or Testes (AALL02P2) (NCT00096135)
Phase N/A
Children's Oncology Group
Children's Oncology Group
Completed
Phase N/A
Children's Oncology Group
Completed
Last update posted :
03/21/2017
Initiation :
11/01/2004
Primary completion :
09/01/2013
CD7
|
cytarabine • cyclophosphamide • etoposide IV • methotrexate • vincristine • daunorubicin • leucovorin calcium • Oncaspar liquid (pegaspargase) • mercaptopurine delayed release (DR6MP) • mercaptopurine • Neupogen (filgrastim) • cyclophosphamide intravenous
Share
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login